Asset Details
Do you wish to reserve the book?
Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines in U.S. Veterans
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines in U.S. Veterans
Do you wish to request the book?
Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines in U.S. Veterans
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines in U.S. Veterans
2022
Overview
In an observational study involving nearly 440,000 veterans, both the BNT162b2 vaccine and the mRNA-1273 vaccine were highly effective at preventing infection, hospitalization, and death from Covid-19. Infection risks were approximately 21% lower with mRNA-1273 than with BNT162b2. Follow-up included periods when either the alpha variant or the delta variant was dominant.
Publisher
Massachusetts Medical Society
Subject
/ Adult
/ Age
/ Aged
/ COVID-19
/ COVID-19 - prevention & control
/ Female
/ Hospitalization - statistics & numerical data
/ Humans
/ Male
/ mRNA
/ Original
/ Severe acute respiratory syndrome coronavirus 2
/ Software
/ United States - epidemiology
/ Vaccine Efficacy - statistics & numerical data
/ Vaccines
/ Veterans
